Results 101 to 110 of about 36,638 (256)

Novel Cereblon‐Binding Immunomodulators Have Increased Potency Against Gammaherpesvirus‐ Associated Lymphomas In Vitro

open access: yesJournal of Medical Virology, Volume 97, Issue 8, August 2025.
ABSTRACT Primary effusion lymphoma (PEL), which is caused by Kaposi sarcoma herpesvirus (KSHV), and Burkitt lymphoma (BL), a subset of which are associated with Epstein‐Barr virus (EBV), are aggressive non‐Hodgkin's lymphomas. Both have relatively poor survival compared to other lymphomas. Cereblon‐binding immunomodulators (CBIs), such as pomalidomide (
Prabha Shrestha   +3 more
wiley   +1 more source

Sarcoma de Kaposi

open access: yesRevista de Ciencias Médicas de Pinar del Río, 2016
El sarcoma de Kaposi ó reticuloendoteliosis angiógena, como también se conoce a esta entidad dermatológica, fue descrito por primera vez por Moritz Kaposi  en 1872 y por un siglo fue una enfermedad rara de varones ancianos.
Liusy Caridad Arías Benitez   +3 more
doaj  

Torque teno virus as a marker of immune status in immunocompromised patients: A systematic review

open access: yesEuropean Journal of Clinical Investigation, Volume 55, Issue 8, August 2025.
Abstract Background Torque teno virus (TTV) is not known to cause disease in humans; however, chronic inflammatory conditions and immunosuppression states can favour TTV replication. This study aimed to verify the effectiveness of TTV as an immune biomarker.
Janaina B. Medina   +8 more
wiley   +1 more source

Causes of death in people living with HIV from a North London cohort between 2006 and 2023: A descriptive analysis

open access: yesHIV Medicine, Volume 26, Issue 8, Page 1258-1266, August 2025.
Abstract Background The provision of highly active anti‐retroviral therapy has improved outcomes for people with HIV, worldwide. There are few data on trends and changes in the cause of death among people with HIV in the United Kingdom since its advent.
Linda Cheyenne Vaccari   +5 more
wiley   +1 more source

Cytotoxic drugs activate KSHV lytic cycle in latently infected PEL cells by inducing a moderate ROS increase controlled by HSF1, NRF2 and p62/SQSTM1 [PDF]

open access: yes, 2018
Previous studies have indicated that cytotoxic treatments may induce or not activate viral lytic cycle activation in cancer cells latently infected by Kaposi’s sarcoma-associated herpesvirus (KSHV). To investigate the molecular mechanisms responsible for
Angiolillo, Camilla   +5 more
core   +1 more source

Iatrogenic colorectal Kaposi sarcoma complicating a refractory ulcerative colitis in a human immunodeficiency negative-virus patient

open access: yesThe Pan African Medical Journal, 2013
Kaposi sarcoma is a mesenchymal tumor associated to a human herpes virus-8. It often occurs in human immunodeficiency virus-positive subjects. Colorectal localization is rare.
Lamine Hamzaoui   +9 more
doaj   +1 more source

Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus

open access: yesInternational Journal of Cancer, Volume 157, Issue 2, Page 371-383, 15 July 2025.
What's new? While estrogens, obesity, and alcohol are recognized risk factors for breast cancer, a viral hypothesis has been suggested based on the murine model of Mouse Mammary Tumor Virus (MMTV)‐induced mammary tumors. This study analyzed sequences of the human homolog of MMTV across human breast carcinoma histotypes, detecting the virus in all types
Prospero Civita   +12 more
wiley   +1 more source

Prevalence of Kaposi’s sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China [PDF]

open access: yes, 2017
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the infectious etiologic agent associated with Kaposi’s sarcoma (KS), primary effusion lymphoma, and multicentric Castleman disease.
Cui, Meng   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy